Structural repertoire of immunoglobulin λ light chains

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 5, 2011, Pages 1513-1524

  Chailyan, Anna ^a   Marcatili, Paolo ^a   Cirillo, Davide ^a   Tramontano, Anna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Canonical structures; Immunoglobulins; Lambda chains

Indexed keywords

IMMUNOGLOBULIN LAMBDA CHAIN;

ANTIGEN RECOGNITION; ARTICLE; CONFORMATION; HUMAN; IMMUNE SYSTEM; IMMUNOGLOBULIN STRUCTURE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS;

ANIMALS; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION;

VERTEBRATA;

EID: 79954591066     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22979     Document Type: Article

References (58)

1. Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970; 132: 211-250.
2. Kabat EA, Wu TT. Construction of a three-dimensional model of the polypeptide backbone of the variable region of kappa immunoglobulin light chains. Proc Natl Acad Sci USA 1972; 69: 960-964.
3. Kabat EA, Wu TT, Bilofsky H. Variable region genes for the immunoglobulin framework are assembled from small segments of DNA-a hypothesis. Proc Natl Acad Sci USA 1978; 75: 2429-2433.
4. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342: 877-883.
5. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006; 24: 541-570.
6. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, Scharff MD. The biochemistry of somatic hypermutation. Annu Rev Immunol 2008; 26: 481-511.
7. Butler JE, Zhao Y, Sinkora M, Wertz N, Kacskovics I. Immunoglobulins, antibody repertoire and B cell development. Dev Comp Immunol 2009; 33: 321-333.
8. Woloschak GE, Krco CJ. Regulation of kappa/lambda immunoglobulin light chain expression in normal murine lymphocytes. Mol Immunol 1987; 24: 751-757.
9. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-242.
10. Murzin AG, Brenner SE, Hubbard T, Chothia C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J Mol Biol 1995; 247: 536-540.
11. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196: 901-917.
12. Tramontano A, Chothia C, Lesk AM. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. J Mol Biol 1990; 215: 175-182.
13. Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 1992; 224: 487-499.
14. Vargas-Madrazo E, Lara-Ochoa F, Almagro JC. Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition. J Mol Biol 1995; 254: 497-504.
15. Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997; 273: 927-948.
16. Almagro JC, Hernandez I, del Carmen Ramirez M, Vargas-Madrazo E. The differences between the structural repertoires of VH germ-line gene segments of mice and humans: implication for the molecular mechanism of the immune response. Mol Immunol 1997; 34: 1199-1214.
17. Almagro JC, Hernandez I, Ramirez MC, Vargas-Madrazo E. Structural differences between the repertoires of mouse and human germline genes and their evolutionary implications. Immunogenetics 1998; 47: 355-363.
18. Vargas-Madrazo E, Paz-Garcia E. Modifications to canonical structure sequence patterns: analysis for L1 and L3. Proteins 2002; 47: 250-254.
19. Kuroda D, Shirai H, Kobori M, Nakamura H. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Proteins 2008; 73: 608-620.
20. Kuroda D, Shirai H, Kobori M, Nakamura H. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 2009; 75: 139-146.
21. Kaas Q, Ruiz M, Lefranc MP. IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res 2004; 32(Database issue): D208-D210.
22. Li W, Jaroszewski L, Godzik A. Clustering of highly homologous sequences to reduce the size of large protein databases. Bioinformatics (Oxford, England) 2001; 17: 282-283.
23. Abhinandan KR, Martin AC. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol Immunol 2008; 45: 3832-3839.
24. Zemla A. LGA-a method for finding 3D similarities in protein structures. Nucleic Acids Res 2003; 31: 3370-3374.
25. Zemla A, Venclovas C, Moult J, Fidelis K. Processing and analysis of CASP3 protein structure predictions. Proteins 1999; 37(Suppl 3): 22-29.
26. Zhang Y, Skolnick J. Scoring function for automated assessment of protein structure template quality. Proteins 2004; 57: 702-710.
27. Peter R. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 1987; 20: 53-65.
28. Archer KJ, Kimes RV. Empirical characterization of random forest variable importance measures. Comp Stat Data Anal 2008; 52: 2249-2260.
29. Breiman L. Random forests. Mach Learn 2001; 45: 5-32.
30. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 2003; 43: 1947-1958.
31. Liaw A, Wiener M. Classification and regression by randomForest. R News 2002; 2: 18-22.
32. Criscitiello MF, Flajnik MF. Four primordial immunoglobulin light chain isotypes, including lambda and kappa, identified in the most primitive living jawed vertebrates. Eur J Immunol 2007; 37: 2683-2694.
33. Vacic V, Iakoucheva LM, Radivojac P. Two Sample Logo: a graphical representation of the differences between two sets of sequence alignments. Bioinformatics (Oxford, England) 2006; 22: 1536-1537.
34. Kabat EA. Antibody gene structure. Science 1979; 203: 400.
35. Wu S, Cygler M. Conformation of complementarity determining region L1 loop in murine IgG lambda light chain extends the repertoire of canonical forms. J Mol Biol 1993; 229: 597-601.
36. Martin AC, Thornton JM. Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J Mol Biol 1996; 263: 800-815.
37. Giudicelli V, Chaume D, Lefranc MP. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 2005; 33(Database issue): D256-D261.
38. Farner NL, Dorner T, Lipsky PE. Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. J Immunol 1999; 162: 2137-2145.
39. Boudinot P, Rueff-Juy D, Drapier AM, Cazenave PA, Sanchez P. Various V-J rearrangement efficiencies shape the mouse lambda B cell repertoire. Eur J Immunol 1995; 25: 2499-2505.
40. Richl P, Stern U, Lipsky PE, Girschick HJ. The lambda gene immunoglobulin repertoire of human neonatal B cells. Mol Immunol 2008; 45: 320-327.
41. Tsubata T, Reth M. The products of pre-B cell-specific genes (lambda 5 and VpreB) and the immunoglobulin mu chain form a complex that is transported onto the cell surface. J Exp Med 1990; 172: 973-976.
42. Hutchinson EG, Thornton JM. A revised set of potentials for beta-turn formation in proteins. Protein Sci 1994; 3: 2207-2216.
43. Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G. Structural repertoire of the human VH segments. J Mol Biol 1992; 227: 799-817.
44. Tomlinson IM, Cox JP, Gherardi E, Lesk AM, Chothia C. The structural repertoire of the human V kappa domain. EMBO J 1995; 14: 4628-4638.
45. Shustik C, Bergsagel DE, Pruzanski W. Kappa and lambda light chain disease: survival rates and clinical manifestations. Blood 1976; 48: 41-51.
46. Husby G. Immunoglobulin-related (AL) amyloidosis. Clin Exp Rheumatol 1983; 1: 353-358.
47. Fields ML, Hondowicz BD, Wharton GN, Adair BS, Metzgar MH, Alexander ST, Caton AJ, Erikson J. The regulation and activation of lupus-associated B cells. Immunol Rev 2005; 204: 165-183.
48. Tobin G, Rosen A, Rosenquist R. What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia? Hematol Oncol 2006; 24: 7-13.
49. North B, Lehmann A, Dunbrack RL, Jr. A new clustering of antibody CDR loop conformations. J Mol Biol doi:10.1016/j.jmb.2010.10.030.
50. Whitelegg NR, Rees AR. WAM: an improved algorithm for modelling antibodies on the WEB. Protein Eng 2000; 13: 819-824.
51. Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics (Oxford, England) 2008; 24: 1953-1954.
52. Sircar A, Kim ET, Gray JJ. RosettaAntibody: antibody variable region homology modeling server. Nucleic Acids Res 2009; 37(Web Server issue): W474-W479.
53. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. Antibody structure, prediction and redesign. Biophys Chem 1997; 68: 9-16.
54. Lazar GA, Desjarlais JR, Jacinto J, Karki S, Hammond PW. A molecular immunology approach to antibody humanization and functional optimization. Mol Immunol 2007; 44: 1986-1998.
55. Nakanishi T, Tsumoto K, Yokota A, Kondo H, Kumagai I. Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10. Protein Sci 2008; 17: 261-270.
56. Schlapschy M, Fogarasi M, Gruber H, Gresch O, Schafer C, Aguib Y, Skerra A. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine lambda to human lambda or kappa light chains. Protein Eng Des Sel 2009; 22: 175-188.
57. Hershberg U, Shlomchik MJ. Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation. Proc Natl Acad Sci USA 2006; 103: 15963-15968.
58. Williams SC, Frippiat JP, Tomlinson IM, Ignatovich O, Lefranc MP, Winter G. Sequence and evolution of the human germline V lambda repertoire. J Mol Biol 1996; 264: 220-232.